Baker Brothers Advisors - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 194 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2017$10,049,000
+0.6%
73,3860.0%0.09%
+7.4%
Q3 2017$9,992,000
+12.2%
73,3860.0%0.08%
+3.8%
Q2 2017$8,909,000
+14.7%
73,3860.0%0.08%
+21.9%
Q1 2017$7,767,000
+4.2%
73,3860.0%0.06%
-12.3%
Q4 2016$7,457,000
-0.4%
73,3860.0%0.07%
+7.4%
Q3 2016$7,490,000
-14.4%
73,3860.0%0.07%
-26.1%
Q2 2016$8,753,000
+11.4%
73,3860.0%0.09%
+10.8%
Q1 2016$7,859,000
-1.2%
73,3860.0%0.08%
+25.8%
Q4 2015$7,957,000
+26.6%
73,3860.0%0.07%
+13.8%
Q3 2015$6,286,000
-15.1%
73,3860.0%0.06%
-10.8%
Q2 2015$7,405,000
+30.9%
73,3860.0%0.06%
+38.3%
Q1 2015$5,659,000
+44.9%
73,386
-0.0%
0.05%
+17.5%
Q4 2014$3,906,000
+13.3%
73,4000.0%0.04%
-7.0%
Q3 2014$3,449,000
-24.6%
73,4000.0%0.04%
-23.2%
Q2 2014$4,572,000
-7.4%
73,4000.0%0.06%
-11.1%
Q1 2014$4,937,00073,4000.06%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Knott David M Jr 115,000$7,6822.90%
VILLERE ST DENIS J & CO LLC 483,347$32,2872.52%
Monarch Partners Asset Management LLC 62,327$4,163,4441.23%
Chicago Capital, LLC 319,054$21,312,8201.18%
RICE HALL JAMES & ASSOCIATES, LLC 285,634$19,080,3511.09%
Stephens Investment Management Group LLC 454,416$30,713,9770.56%
Smith, Graham & Co., Investment Advisors, LP 65,372$4,366,8500.53%
WOODSTOCK CORP 55,014$3,674,9350.49%
Court Place Advisors, LLC 15,533$1,037,6050.38%
ISTHMUS PARTNERS, LLC 19,830$1,324,6440.20%
View complete list of LIGAND PHARMACEUTICALS INC shareholders